Skip to main content
TipRanks
Go Ultimate75% OFF

Mettler-Toledo (MTD) AI Stock Analysis

522 Followers
MTD

Mettler-Toledo

(NYSE:MTD)

Select Model
Rating:75Outperform
Price Target:$1,889.00â–²(8.63% Upside)
Action:reiterated
Date:11/06/26

MTD scores well due to strong profitability and free-cash-flow generation, reinforced by a bullish technical backdrop and a notably positive earnings outlook (raised 2026 outlook and solid 2027 EPS growth guidance). The score is held back primarily by balance-sheet risk (thin/volatile equity and meaningful debt) and a premium valuation (P/E ~36).

Positive Factors
Recurring Service BaseService revenue adds a recurring component to equipment sales by supporting calibration, maintenance, repairs, parts, and compliance needs across the installed base. This increases customer retention and makes revenue less dependent on new instrument purchases or individual capital-spending cycles.
Negative Factors
Meaningful LeverageDebt is large relative to the company’s thin equity cushion, and equity has been negative in several annual periods. This leaves less protection if operating conditions weaken and can constrain financial flexibility for investment, acquisitions, or shareholder returns.

Mettler-Toledo Key Performance Indicators (KPIs)

Revenue By SegmentAnalyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.

$0.00$250.00M$500.00M$750.00M$1.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Industrial is clearly the growth engine — recent quarters show accelerating, consistent gains that drove the company’s top‑line beat — while Laboratory has recovered from earlier softness and now supplies a large, stable revenue base. Retail is volatile and too small to offset swings in the bigger segments. Management’s call confirms this mix: acquisitions are a minor sales kicker and U.S. import tariffs are the principal margin risk that could mute EPS upside even if sales continue to improve into 2026.

Data provided by:The Fly

Mettler-Toledo (MTD) vs. SPDR S&P 500 ETF (SPY)

-30%-20%-10%0%10%20%30%MTD+24.52%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$34.59B
Dividend Yield
―
Average Volume (3M)
200.00K
Price to Earnings (P/E)
37.6
Beta (1Y)
0.94
Revenue Growth
6.51%
EPS Growth
15.03%
Country
US
Employees
16,600
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

Mettler-Toledo Business Overview & Revenue Model

Company Description

Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domes...

How the Company Makes Money

Mettler-Toledo primarily makes money by selling precision measurement and inspection equipment and by providing recurring services that support those installed instruments. Key revenue streams include: (1) Instrument and system sales: revenue from th...

Mettler-Toledo Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:3.56%|Next Earnings Date:Feb 11, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. The company reported broad-based 6% organic sales growth, 13% adjusted EPS growth, improved margins, strong momentum in China and emerging markets, a raised 2026 outlook, and 10% to 12% expected adjusted EPS growth for 2027. Management also highlighted improving laboratory demand, automation and digitalization opportunities, strategic investments, and growing onshoring activity. The main cautions were subdued European conditions, food retail and near-term product-inspection softness, higher material and transportation costs, tariff and foreign-exchange uncertainty, difficult China comparisons, and the extended timing of onshoring benefits. Highlights significantly outweighed the lowlights.

Positive Updates

Broad-Based Third-Quarter Growth
Third-quarter sales were $1.1 billion, up 6% in U.S. dollars and local currencies, with organic local-currency sales also up 6%. Growth was broad based across the portfolio and benefited from improving market demand, stronger sales volume, and execution of strategic initiatives.

Negative Updates

Food Retail Sales Decline
Food retail organic sales declined 2% in the quarter, primarily because of the timing of project activity, especially in the Americas. Management expects food retail growth in the low single digits in 2027.

Company Guidance

For the fourth quarter of 2026, local currency sales growth is forecast at approximately 5%, adjusted EPS is forecast to be in the range of $14.84 to $15.04, representing a growth rate of 11% to 13%, and pricing is expected to be in that 2.5 percent range; for full year 2026, local currency sales growth is forecast at approximately 5%, reflecting organic growth of 4%, and adjusted EPS is forecast to be in the range of $47.70 to $47.90, representing a growth rate of 12%. For 2027, local currency sales are expected to increase approximately 5%, adjusted EPS is forecast to be in the range of $52.50 to $53.50, representing a growth rate of 10% to 12%, foreign exchange is estimated to be a 1% headwind to sales growth and neutral to EPS, price is expected to be just over 2% and volume in the 3% ish kind of a range, lab is guided mid to high single digit, core industrial mid-single-digit, product inspection low to mid single digit, food retailing low single digit, The Americas mid to high single digit, Europe low single digit, and China mid single digit; total amortization is expected to be approximately $76 million, purchased intangible amortization approximately $27 million on a pretax basis for approximately $1 per share, interest expense $68 million, other income approximately $22 million, the tax rate before discrete items 18%, free cash flow approximately $950 million, representing 8% growth on a per share basis, and share repurchases $950 million.

Mettler-Toledo Financial Statement Overview

Summary

Strong profitability and cash generation (TTM net margin ~21%–22%, TTM FCF ~$871M with ~0.88x net-income conversion) support a solid score, but it is materially constrained by balance-sheet risk: meaningful leverage (~$2.0–$2.3B debt) and historically thin/negative equity, leaving limited cushion if operating conditions weaken. A watch item is the TTM step-down in EBIT margin (~21%) versus prior annual levels (~27%–29%).

Income Statement

86Very Positive

Balance Sheet

48Neutral

Cash Flow

82Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.20B4.03B3.87B3.79B3.92B3.72B
Gross Profit2.48B2.39B2.25B2.17B2.24B2.11B
EBITDA1.33B1.24B1.25B1.20B1.24B1.10B
Net Income934.07M869.19M863.14M788.78M872.50M768.99M
Balance Sheet
Total Assets3.70B3.71B3.24B3.36B3.49B3.33B
Cash, Cash Equivalents and Short-Term Investments52.24M66.89M59.36M69.81M95.97M98.56M
Total Debt2.02B2.34B2.13B2.20B2.13B1.80B
Total Liabilities3.62B3.74B3.37B3.51B3.47B3.16B
Stockholders Equity77.66M-23.64M-126.89M-149.94M24.79M171.42M
Cash Flow
Free Cash Flow870.57M848.65M864.45M860.55M737.83M801.25M
Operating Cash Flow984.37M955.77M968.35M965.87M859.07M908.83M
Investing Cash Flow-84.27M-193.87M-119.46M-131.69M-139.40M-314.11M
Financing Cash Flow-921.82M-755.17M-855.98M-859.59M-716.04M-590.55M

Mettler-Toledo Technical Analysis

Technical Analysis SentimentPositive
Last Price1738.91

Price Trends

50DMA1560.60Positive
100DMA1459.58Positive
200DMA1352.19Positive

Market Momentum

MACD48.92Positive
RSI64.13Neutral
STOCH53.29Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTD, the sentiment is Positive. The current price of 1738.91 is above the 20-day moving average (MA) of 1698.63, above the 50-day MA of 1560.60, and above the 200-day MA of 1352.19, indicating a bullish trend. The MACD of 48.92 indicates Positive momentum. The RSI at 64.13 is Neutral, neither overbought nor oversold. The STOCH value of 53.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTD.

Mettler-Toledo Risk Analysis

Mettler-Toledo disclosed 29 risk factors in its most recent earnings report. Mettler-Toledo reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Changes in foreign laws and legal systems could adversely impact our results of operations.Q4, 2024
2.We may be adversely affected by failure to comply with regulations of governmental agencies or by the adoption of new regulations.Q4, 2024
3.Climate change, or the effects of climate change, may negatively affect us.Q4, 2024

Mettler-Toledo Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

MTD against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AA78Outperform$49.04B34.1820.47%0.59%8.60%19.07%
TMOTMO77Outperform$259.44B36.8713.31%0.26%8.27%9.59%
ILMNILMN75Outperform$31.30B35.1531.45%―6.00%31.48%
MTDMTD75Outperform$34.59B37.599999.00%―6.51%15.03%
DHRDHR73Outperform$163.94B38.088.18%0.65%5.52%25.53%
WATWAT59Neutral$45.24B195.850.81%―80.68%-78.49%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%50%100%MTDADHRILMNTMOWATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MTD and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MTDMettler-toledo International1738.91349.9525.20%
AAgilent Technologies173.9630.5221.27%
DHRDanaher Corporation233.0214.206.49%
ILMNIllumina207.0186.9372.39%
TMOThermo Fisher Scientific700.22135.0523.89%
WATWaters Corp460.2582.2721.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026